Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion

Viral Immunology Aug 2016, Vol. 29, No. 6: 332-342.
Source: Viral Immunology - Category: Allergy & Immunology Authors: Source Type: research